Targeting CI reduced tumorigenic potential of 143B cells at day 30, but this antitumorigenic effect was less appreciated by day 60, when tumor size and Ki-67 proliferation index were similar between the two groups (Figure 1b,c). This evidence concerns the gene MKI67 and neoplasm.